INTRODUCTION {#sec1-1}
============

Periodontal disease is a microbe-induced chronic inflammatory condition affecting periodontium. The incidence and progression of this disease is related to substantial increase in gram-negative anaerobic rods. Among them, *Porphyromonas gingivalis* and *Aggregatibacter actinomycetemcomitans* are strongly implicated in periodontitis.\[[@ref1]\]

Apart from bacteria, tissue destruction can be enhanced by uncontrolled host immune response to infection. Diabetes is one such condition that affects multitude of tissues and organs including periodontium. It alters the host immuno-inflammatory responses, such as upregulation of inflammatory cell phenotype, elevation of proinflammatory cytokines, increased collagenase activity, and production of reactive oxygen species, thus enhancing the possibility of risk and prevalence of periodontitis.\[[@ref2][@ref3][@ref4][@ref5][@ref6][@ref7]\]

The periodontal therapy is directed at controlling the bacterial flora, which has often proven to be difficult by mechanical depuration alone than expected, thus providing a rationale for the adjunctive use of chemotherapeutic agents.\[[@ref8][@ref9]\] Various locally delivered antimicrobials have been used aiming at inhibition of the pathogens or modulation of the inflammatory response, which include tetracycline, metronidazole, doxycycline, minocycline, and chlorhexidine.\[[@ref10][@ref11][@ref12][@ref13][@ref14][@ref15]\]

Of late, many natural products are used for the treatment of periodontitis. Green tea (*Camellia sinensis*) extract is one among them which has various therapeutic effects such as antioxidant,\[[@ref16]\] anti-collagenase,\[[@ref17]\] anti-inflammatory,\[[@ref18]\] anticaries,\[[@ref19]\] antifungal, antiviral,\[[@ref20]\] and antibacterial effects.\[[@ref21]\] Even in the field of medicine, epidemiological and experimental observations have suggested anti-obesity,\[[@ref22][@ref23]\] anticarcinogenic,\[[@ref24]\] cardioprotective effects,\[[@ref25]\] anti-diabetic activity,\[[@ref26][@ref27][@ref28]\] and also causing inhibition of bone resorption and increase in bone mineral density.\[[@ref16]\]

Hence, in the present study, an attempt was made to evaluate the effect of green tea extract as a local antimicrobial agent using hydroxypropyl methylcellulose (HPMC) on chronic periodontitis patients associated with and without diabetes mellitus, using clinical and microbiological parameters.

MATERIALS AND METHODS {#sec1-2}
=====================

*In vitro* study {#sec2-1}
----------------

### Preparation of the strips {#sec3-1}

Green tea catechin strips were prepared by the method described by Hirasawa *et al*.\[[@ref21]\] In brief, 3.876 g of HPMC and 0.204 g of green tea extract (Geltec Pvt. Ltd, Bengaluru, India) were taken in a clean mortar. Both were ground to a fine powder with pestle, blending the contents by grinding. The entire quantity of the above mixture was carefully transferred to a 500-ml beaker. The mixture was first made to a paste by adding little ethanol. The paste was diluted further by addition of ethanol with simultaneous stirring, ensuring that the constituents were evenly dispersed. A total of 160 ml ethanol was added to the mixture and stirring was done for 1 h.

The whole contents of the beaker were transferred to a clean reflux flask (250 ml) without any spillage. A clean Teflon magnetic paddle was dropped inside the flask and the condenser was attached. The flask with condenser was placed upon a magnetic stirrer. Stirring was set without splashing of ethanol inside the flask. The stirring process was carried out overnight.

Later, a clean Teflon-coated tray of inner size 11.5 cm × 11.5 cm was placed inside a laminar air flow station. The content of the flask was poured into the tray and allowed for drying. After drying was complete, the sheet was released from the tray aseptically. The dried product in the sheet form was put to the punch die of the required shape and size (4 mm width × 5 mm length with rounded corners on one side). After punching in the strip form, strips of thickness 200-300 μm were selected.

Placebo strips were prepared in a similar manner without adding the green tea extract powder to HPMC powder. The entire operation was performed under aseptic conditions in a clean environment. The strips were individually packed in a medical grade pouch and sterilized by gamma irradiation at 2.5 Mrd.

### Estimation of drug release {#sec3-2}

Drug release pattern was analyzed using UV spectrophotometer. Estimation was carried out in 100 ml of distilled water in a beaker maintained at a temperature of 37 ± 1°C. A sample of 5 ml was collected at regular intervals (30, 60, 90, and 120 min) and checked for peak absorbance at 273 nm. Five milliliters of fresh distilled water was added after removing the sample in order to maintain sink condition. The films were dissolved in ethanol--water mixture, and the total extract present in the film was assayed by measuring the absorbance at 273 nm.

*In vivo* study {#sec2-2}
---------------

### Clinical study design {#sec3-3}

A randomized, placebo-controlled, parallel-group, single-evaluator--blinded study with split-mouth design was conducted for 4 weeks. The sample size of 50 patients (i.e., 25 patients in each group) was estimated to achieve 90% power to detect a difference of 1.0 between the null hypotheses and alternative mean through Creative Research Systems. Outpatients from both sexes with age limit of 20-65 years were selected from Department of Periodontics, Narayana Dental College, Andhra Pradesh, India from May 2009 to December 2009.

The inclusion criteria were: 1) Patients with chronic periodontitis with pocket depth of \>4 mm and radiographic evidence of bone loss bilaterally and 2) those willing to take part in the study and maintain their appointment regularly. The exclusion criteria were: 1) Patients having systemic diseases other than diabetes mellitus; 2) those who have received any topical or systemic antimicrobial treatment or periodontal treatment in the past 6 months; 3) pregnant and lactating mothers; and 4) smokers. The study protocol was reviewed and approved by the institutional and university ethical board.

Criteria for grouping and randomizations {#sec2-3}
----------------------------------------

Group 1: 25 systemically healthy patients with chronic periodontitis

Group 2: 25 diabetic patients with chronic periodontitis.

All patients were subjected to supragingival scaling and given oral hygiene instructions. In each patient of both the groups, two contralateral target sites were selected and randomly assigned following simple randomization procedure (computerized random numbers) into test and control sites to receive green tea and placebo strips, respectively.

The green tea and placebo strips were numbered G1-G200 and P1--P200, respectively. After proper isolation of the selected area, a dental hygienist inserted the strips subgingivally with a tweezer at baseline, first, second, and third weeks in test and control sites. Later, the evaluator made recordings of the post-insertion clinical parameters at different intervals without any knowledge of the sites allocated. At the end of the study, decoding was done to compare and relate the data.

Clinical parameters {#sec2-4}
-------------------

Gingival Index (GI), Probing Pocket Depth (PPD), and Clinical Attachment Level (CAL) were recorded using periodontal probe (Hu-Friedy, Chicago, United States) at baseline, first, second, third, and fourth weeks. All the parameters were assessed at the test and control sites \[[Figure 1](#F1){ref-type="fig"}\].

![Study design: Following screening and grouping, test and control sites were selected. Microbial plaque samples were collected and clinical measurements recorded at baseline, and green tea and placebo strips were placed in the test and control sites, respectively. Placement of strips was repeated at first, second, and third weeks after recording the clinical parameters. At the fourth week, clinical parameters and microbial plaque samples were collected](JISP-17-198-g001){#F1}

Microbiological analysis {#sec2-5}
------------------------

The subgingival plaque was collected using a sterile Gracey curette (Hu-Friedy). The samples were then transferred to Eppendorf vial containing Tris-ethylenediaminetetraacetic acid (EDTA) buffer and sent for microbiological analysis for the detection of *A. actinomycetemcomitans*, and *P. gingivalis* by multiplex polymerase chain reaction (PCR) at baseline. Similar procedure was repeated at the end of fourth week. Microbiological analysis was performed for 32 sites (16 control sites and 16 test sites).

Statistical analysis {#sec2-6}
--------------------

Data shown are from three separate experiments (*in vitro*, *in vivo*, and microbiological) that were analyzed statistically by descriptive statistics, independent-samples *t*-test, paired samples *t*-test, and repeated-measures analysis of variance (ANOVA). Contingency coefficient (CC) test was used to analyze the association between the occurrence of microorganisms at baseline and fourth week postoperatively. All the statistical methods were carried out through SPSS for Windows (version 16.0).

RESULTS {#sec1-3}
=======

The *in vitro* release pattern of the green tea catechin strips at different time intervals (30, 60, 90, and 120 min) was evaluated, and the amount of drug released was 2.826 μg/ml (10.67%), 6.669 μg/ml (35.98%), 10.485 μg/ml (75.61%), and 8.688 μg/ml (108%), respectively \[[Table 1](#T1){ref-type="table"}\].

###### 

*In vitro* release pattern of the green tea catechin strips at different time intervals

![](JISP-17-198-g002)

*In vivo* study: One patient from the non-diabetic group (*n* = 24) and two patients from the diabetic group (*n* = 23) missed the appointments after baseline assessment and were excluded from the study.

When GI scores were compared between the groups at different intervals and at study sites, they showed statistically high significance (*P* \< 0.001), whereas no significance was observed when the comparison was made between diabetic and non-diabetic groups \[[Figure 2](#F2){ref-type="fig"}\].

![Comparison of gingival index scores between non-diabetic (n = 24) and diabetic (n = 23) groups at different intervals](JISP-17-198-g003){#F2}

On comparison of PPD between the groups at different intervals, high significance (*P* \< 0.001) was observed from baseline to the end of fourth week. However, the quantum of change varied in different groups, showing high significance in the non-diabetic group \[[Figure 3](#F3){ref-type="fig"}\].

![Comparison of probing pocket depth between non-diabetic and diabetic groups at different intervals](JISP-17-198-g004){#F3}

Comparison of CAL between the groups at different intervals showed statistically significant difference (*P* \< 0.001) from baseline to fourth week. The quantum of change varied in different groups, whereas with respect to the comparison between the groups, high significant change was observed with respect to the diabetic group \[[Figure 4](#F4){ref-type="fig"}\].

![Comparison of clinical attachment level between non-diabetic and diabetic groups at different intervals](JISP-17-198-g005){#F4}

When the comparison of occurrence of *P. gingivalis* was made in the non-diabetic group, a significant association was observed in the incidence with the duration, which was statistically significant at 5% level (CC = 0.44, *P* \< 0.046) in the test site, whereas no significance was found in the control site. In the diabetic group, there was no significant association at the control site (CC = 0.43, *P* \< 0.055) and test site (CC = 0.32, *P* \< 0.189). However, five sites showed incidence for the organism at baseline and only two sites were positive at the end of fourth week in the test site \[[Table 2](#T2){ref-type="table"}\].

###### 

Comparison of occurrence of *P. gingivalis* at different sites in non-diabetic and diabetic groups and at baseline and 4-week intervals

![](JISP-17-198-g006)

When the occurrence of *A. actinomycetemcomitans* was compared in both groups, no significant association was observed \[[Table 3](#T3){ref-type="table"}\].

###### 

Comparison of occurrence of *A. actinomycetemcomitans* at different sites in the non-diabetic and diabetic groups and at baseline and 4-week intervals

![](JISP-17-198-g007)

DISCUSSION {#sec1-4}
==========

The *in vitro* study showed 10.67% of green tea release at 30 min, thereafter a slow release of the remaining green tea, and then at 120 min, it ended with complete release leading to maximum availability of the drug, which was in accordance with the reports of Hirasawa *et al*.,\[[@ref21]\] Noguchi *et al*.,\[[@ref29]\] and Soskolne.\[[@ref30]\]

The *in vivo* study was conducted for 4 weeks period because healing of periodontium following nonsurgical therapy demonstrates an initial gain of clinical attachment at 3 weeks. Healing of a new dentogingival junction takes at least 4 weeks and no further gain in clinical attachment occurs in the subsequent 3 months.\[[@ref31][@ref32]\]

Both the groups in our study showed significant reduction in gingival inflammation at the test sites, similar to that reported by Hirasawa *et al*.\[[@ref21]\] This may be due to the well-controlled antioxidant effect scavenging the increased reactive oxygen and nitrogen species\[[@ref33][@ref34][@ref35]\] at the diseased periodontal sites.\[[@ref36][@ref37][@ref38][@ref39]\] Also, (−)-epigallocatechin gallate (EGCG) of green tea inhibits lipooxygenases and cyclooxygenases (COX), which are responsible for the production of prostaglandin E2 (PGE2).\[[@ref40][@ref42]\] EGCG also inhibits the mRNA expression of COX-2, matrix metalloproteinase (MMP)-1, and interleukin (IL)-1, -6, and -8 by the cultured cells.\[[@ref43]\]

The diabetic and non-diabetic groups showed significant PPD reduction similar to that reported by Hirasawa *et al*.\[[@ref21]\] Faster reduction in PPD was observed in the non-diabetic group than in the diabetic group. This may be due to the inhibitory effect of green tea catechins on cysteine proteinases (Arg-gingipain and Lys-gingipain) of *P. gingivalis*\[[@ref44]\] and protein tyrosine phosphatase of *P. intermedia*,\[[@ref45]\] which are considered as potent virulence factors in the development of periodontitis.\[[@ref46][@ref47][@ref48]\] This may also be because of absorption of green tea into the epithelial cells in the subgingival pocket, thus inhibiting the growth of black pigmented rods responsible for periodontal disease.

Gain in CAL at the test sites was 1.33 mm in the non-diabetic group and 1.43 mm in the diabetic group, consistent with the report of Yun *et al*.\[[@ref49]\] and Makimura *et al*.\[[@ref17]\] They observed that green tea catechins can inhibit collagenase activity and prevent alveolar bone resorption, and this may help in preventing periodontal disease progression.\[[@ref50]\]

Even though bacterial culture is the "gold standard" microbiological assay, it is now accepted that PCR technology provides a more sensitive means of detection, as compared to the culture technique for putative bacterial species.\[[@ref51]\] Hence, the microbiological assessment was performed using multiplex PCR showing the incidence of *P. gingivalis* and *A. actinomycetemcomitans*.

In the present study, the prevalence of *P. gingivalis* in the non-diabetic test sites was significantly reduced from baseline (75%) to fourth week (25%), suggesting the antimicrobial effects of green tea catechins, whereas in the control sites, it remained unchanged. In the diabetic test sites, there was no statistically significant association; however, 71.4% showed incidence for the organism at baseline and only 28.6% were positive at the fourth week. These results indicate that green tea catechin was effective in treating *P. gingivalis* infection. Moreover, reduction in *P. gingivalis* at the positive sites was accompanied by clinical improvement.

The incidence of *A. actinomycetemcomitans* in both the groups was not significant in accordance with the reports of Ali *et al*.,\[[@ref52]\] Conrads *et al*.,\[[@ref53]\] and Umeda *et al*.\[[@ref54]\] The baseline data indicated that *A. actinomycetemcomitans* was present in 12.5% of the sampled sites. This could be because *A. actinomycetemcomitans* and *P. gingivalis* are rarely detected in the same periodontal site as reported by Yoshida *et al*.\[[@ref52][@ref55]\]

However, the short-term trial period and early dissolution of the strips may warrant further interventions to consider the long-term benefits of green tea as a local drug therapy.

CONCLUSION {#sec1-5}
==========

Green tea catechin strip can be used as an adjunct to scaling and root planing in the treatment of chronic periodontitis both in diabetic and non-diabetic patients. Its continuous application on a daily basis may be a useful and practical method in the treatment of periodontal disease.
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